✦ LIBER ✦

P428 New opportunities overcoming of the secondary inefficiencies of the anticytokine therapy in patients with inflammatory bowel disease

✍ Scribed by Knyazev, O.; Sagynbaeva, V.; Ruchkina, I.; Parfenov, A.; Shcherbakov, P.; Konoplyannikov, A.; Lazebnik, L.

Book ID: 122703087
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 53 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60449-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unfractioned heparin in the therapy of p

Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease

✍ C Folwaczny; B Wiebecke; K Loeschke 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

P647 2-year incidence of new immune-medi

P647 2-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease. The AQUILES study

✍ Marín-Jiménez, I.; García, V.; Pérez-Gisbert, J.; Pérez-Calle, J.L.; Luján, M.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 64 KB

TREATMENT OF HÆMORRHOIDS IN PATIENTS WIT

TREATMENT OF HÆMORRHOIDS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

✍ Jeffery, P.J.; Ritchie, JeanK.; Parks, A.G. 📂 Article 📅 1977 🏛 The Lancet 🌐 English ⚖ 270 KB

P062 - Impact of capsule endoscopy in th

P062 - Impact of capsule endoscopy in the management of patients with inflammatory bowel disease

✍ L. Márquez; B. Gonzalez; B. Gras; I. Ibáñez; X. Bessa; J. Dedeu; A. Cañas-Ventur 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 48 KB

Quality of life in Chinese patients with

Quality of life in Chinese patients with inflammatory bowel disease: Validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire

✍ Leong, Rupert; Lee, Yuk T.; Ching, Jessica Y.; Sung, Joseph J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Lost in translation: Helping patients un

Lost in translation: Helping patients understand the risks of inflammatory bowel disease therapy

✍ Corey A. Siegel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Patients with inflammatory bowel disease are commonly treated with immunomodulators and biologic therapy. These treatments can be very effective, but are associated with risks of adverse events that need to be discussed with patients. Effectively communicating risks of therapy can be challenging bas